Increasing high-density lipoprotein cholesterol: an update on fenofibrate
- 1 December 2001
- journal article
- review article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 88 (12) , 30-36
- https://doi.org/10.1016/s0002-9149(01)02150-6
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- A New Formulation of Fenofibrate: Suprabioavailable TabletsCurrent Medical Research and Opinion, 2000
- Atherogenic lipoprotein phenotype in Type 2 diabetes: reversal with micronised fenofibrateDiabetes/Metabolism Research and Reviews, 1999
- Micronised fenofibrate or gemfibrozil in patients with combined hyperlipidaemia: A double-blind randomised multicentre trialAtherosclerosis, 1999
- Micronised FenofibrateDrugs, 1997
- High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transportAtherosclerosis, 1996
- Multicenter Comparison of Micronized Fenofibrate and Simvastatin in Patients with Primary Type IIA or IIB HyperlipoproteinemiaJournal of Cardiovascular Pharmacology, 1996
- Micronised fenofibrateAtherosclerosis, 1994
- Efficacy and tolerance of 200 mg micronised fenofibrate administered over a 6-month period in hyperlipidaemic patients: An open Belgian multicenter studyAtherosclerosis, 1994
- FenofibrateDrugs, 1990